143 related articles for article (PubMed ID: 8372162)
1. The P50 component of the auditory evoked potential and subtypes of schizophrenia.
Boutros N; Zouridakis G; Rustin T; Peabody C; Warner D
Psychiatry Res; 1993 Jun; 47(3):243-54. PubMed ID: 8372162
[TBL] [Abstract][Full Text] [Related]
2. Dopaminergic modulation of the P50 auditory-evoked potential in a computer model of the CA3 region of the hippocampus: its relationship to sensory gating in schizophrenia.
Moxon KA; Gerhardt GA; Adler LE
Biol Cybern; 2003 Apr; 88(4):265-75. PubMed ID: 12690485
[TBL] [Abstract][Full Text] [Related]
3. [The P 300 potential in schizophrenia].
Laurent A; Garcia-Larrea L; Dalery J; Terra JL; D'Amato T; Marie-Cardine M; Mauguière F
Encephale; 1993; 19(3):221-7. PubMed ID: 8275907
[TBL] [Abstract][Full Text] [Related]
4. Effects of medication history on midlatency auditory evoked responses in schizophrenia.
Erwin RJ; Shtasel D; Gur RE
Schizophr Res; 1994 Feb; 11(3):251-8. PubMed ID: 7910754
[TBL] [Abstract][Full Text] [Related]
5. Auditory sensory gating and catecholamine metabolism in schizophrenic and normal subjects.
Waldo M; Gerhardt G; Baker N; Drebing C; Adler L; Freedman R
Psychiatry Res; 1992 Oct; 44(1):21-32. PubMed ID: 1461944
[TBL] [Abstract][Full Text] [Related]
6. Sensory gating revisited: relation between brain oscillations and auditory evoked potentials in schizophrenia.
Brockhaus-Dumke A; Mueller R; Faigle U; Klosterkoetter J
Schizophr Res; 2008 Feb; 99(1-3):238-49. PubMed ID: 18160261
[TBL] [Abstract][Full Text] [Related]
7. P50 suppression among schizophrenia and normal comparison subjects: a methodological analysis.
Clementz BA; Geyer MA; Braff DL
Biol Psychiatry; 1997 May; 41(10):1035-44. PubMed ID: 9129784
[TBL] [Abstract][Full Text] [Related]
8. Varied effects of atypical neuroleptics on P50 auditory gating in schizophrenia patients.
Adler LE; Olincy A; Cawthra EM; McRae KA; Harris JG; Nagamoto HT; Waldo MC; Hall MH; Bowles A; Woodward L; Ross RG; Freedman R
Am J Psychiatry; 2004 Oct; 161(10):1822-8. PubMed ID: 15465979
[TBL] [Abstract][Full Text] [Related]
9. Normal p50 gating in unmedicated schizophrenia outpatients.
Arnfred SM; Chen AC; Glenthøj BY; Hemmingsen RP
Am J Psychiatry; 2003 Dec; 160(12):2236-8. PubMed ID: 14638598
[TBL] [Abstract][Full Text] [Related]
10. Normalization of auditory sensory gating in schizophrenic patients after a brief period for sleep.
Griffith JM; Waldo M; Adler LE; Freedman R
Psychiatry Res; 1993 Oct; 49(1):29-39. PubMed ID: 8140180
[TBL] [Abstract][Full Text] [Related]
11. Differences between paranoid and nonparanoid schizophrenic patients on the somatosensory P300 event-related potential.
Louzã MR; Maurer K
Neuropsychobiology; 1989; 21(2):59-66. PubMed ID: 2615924
[TBL] [Abstract][Full Text] [Related]
12. Effects of P50 temporal variability on sensory gating in schizophrenia.
Jin Y; Potkin SG; Patterson JV; Sandman CA; Hetrick WP; Bunney WE
Psychiatry Res; 1997 May; 70(2):71-81. PubMed ID: 9194201
[TBL] [Abstract][Full Text] [Related]
13. Cocaine use and the mid-latency auditory evoked responses.
Boutros N; Campbell D; Petrakis I; Krystal J; Caporale M; Kosten T
Psychiatry Res; 2000 Oct; 96(2):117-26. PubMed ID: 11063784
[TBL] [Abstract][Full Text] [Related]
14. Neuroleptic effects on P50 sensory gating in patients with first-episode never-medicated schizophrenia.
Hong X; Chan RC; Zhuang X; Jiang T; Wan X; Wang J; Xiao B; Zhou H; Jiang L; Weng B
Schizophr Res; 2009 Mar; 108(1-3):151-7. PubMed ID: 19106034
[TBL] [Abstract][Full Text] [Related]
15. Neurophysiological and neuropsychological evidence for attentional dysfunction in schizophrenia.
Cullum CM; Harris JG; Waldo MC; Smernoff E; Madison A; Nagamoto HT; Griffith J; Adler LE; Freedman R
Schizophr Res; 1993 Aug; 10(2):131-41. PubMed ID: 8398945
[TBL] [Abstract][Full Text] [Related]
16. Midlatency auditory evoked responses in schizophrenia.
Erwin RJ; Mawhinney-Hee M; Gur RC; Gur RE
Biol Psychiatry; 1991 Sep; 30(5):430-42. PubMed ID: 1932393
[TBL] [Abstract][Full Text] [Related]
17. P50 gating in deficit and nondeficit schizophrenia.
Santos JL; Sánchez-Morla EM; Aparicio A; García-Jiménez MA; Villanueva C; Martínez-Vizcaíno V; Arango C
Schizophr Res; 2010 Jun; 119(1-3):183-90. PubMed ID: 20153607
[TBL] [Abstract][Full Text] [Related]
18. [P50 component of auditory evoked potentials in persons with schizophrenia and their first degree relatives].
Wegrzyn J; Wciórka J
Psychiatr Pol; 2004; 38(3):395-408. PubMed ID: 15199650
[TBL] [Abstract][Full Text] [Related]
19. Neurophysiological evidence for a defect in inhibitory pathways in schizophrenia: comparison of medicated and drug-free patients.
Freedman R; Adler LE; Waldo MC; Pachtman E; Franks RD
Biol Psychiatry; 1983 May; 18(5):537-51. PubMed ID: 6134559
[TBL] [Abstract][Full Text] [Related]
20. Normalization of auditory physiology by cigarette smoking in schizophrenic patients.
Adler LE; Hoffer LD; Wiser A; Freedman R
Am J Psychiatry; 1993 Dec; 150(12):1856-61. PubMed ID: 8238642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
